Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial

We conducted a prospective phase II multicentric trial to determine if radical radiation therapy to all metastatic sites might improve the progression-free survival (PFS) in oligometastatic breast cancer patients. Secondary endpoints were local control (LC), overall survival (OS) and toxicity.

http://ift.tt/2fkAgQD